Botox Market Worth US$ 10.60 Billion By 2030 And Is Anticipated To Register A CAGR Of 7.50%. BY PMI
Date
3/27/2023 7:45:45 PM
(MENAFN- EIN Presswire) Botox market PMI
Botox Market, By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) – Trends, Analysis, and Forecast till 2030
COVINA, CALIFORNIA , UNITED STATES, March 27, 2023/einpresswire.com / -- The botox market accounted for US$ 5.15 billion in 2020 and is estimated to be US$ 10.60 billion by 2030 and is anticipated to register a CAGR of 7.50%. Global botox market is driven by escalating population aging between 25 years to 65 years to age, surging demand for minimally invasive treatment and escalating therapeutic utility of botulinum toxin. Botox is more financially viable for patients, botox injections are less invasive than other cosmetic procedures, and it is a versatile treatment, owing to fuel demand of the global botox market. Heavy investment on R&D projects to develop the therapeutic use of botox is creating numerous opportunities in the global botox market across the globe.
The report "Botox Market, By Type (Botulinum Toxin Type-A and Botulinum Toxin Type-B), By End-use (Therapeutic Use and Aesthetic Use), and Region - Global Forecast to 2029”.
Key Highlights:
.On August 2016, Ipsen Pharma SA has announced first FDA-approved botulinum toxin Dysport® for the treatment of pediatric lower limb spasticity and has studied in patients having cerebral palsy
.On May 2019, Merz Pharma a global leader in neurotoxin therapy has announced the European approval of Xeomin® for the symptomatic treatment of chronic sialorrhea owing to neurological disorders in adult patients
.On March 2019, Medy-Tox Inc., a leading botulinum toxin producer has launched Coretox, a new botulinum toxin type A product aimed to reduce the risk of resistance which is an ongoing concern after repeated injections.
Request Sample:
Market Segmentation:
.By Type- Botulinum Toxin Type-A and Botulinum Toxin Type-B
.By End-User- Therapeutic use and Aesthetic use
Regional scope:
.North America - U.S., Canada
.Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe
.Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific
.Latin America - Brazil, Mexico, Argentina, Rest of Latin America
.Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Regional Insights:
For detailed understanding of market dynamics, on the basis of region, the global botox market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is the largest supplier of botox, and dominates the global botox market, owing to the rise in awareness level regarding non-surgical esthetic and therapeutic procedures. The global market in North America is expected to maintain its dominant position over the forecast period. The global market in Europe is the second largest supplier of botox, and is expected to expand over the forecast period, due to increase in geriatric population. The global market in Asia Pacific is projected to expand over the forecast period, owing to the rise in adoption of non-surgical botulinum toxin procedures by the geriatric population and favorable government regulations.
Key Market Insights from the report:
The Botox Market accounted for US$ 5.15 billion in 2020 and is estimated to be US$ 10.60 billion by 2030 and is anticipated to register a CAGR of 7.50%. over the forecast period. The market report has been segmented on the basis of type, end-use, and region.
.By type, the botulinum toxin type-A segment held a prominent share of the global botox market in 2018. Increase in prevalence of cervical dystonia, spasticity, glabellar lines, and crow's foot and rise in the use of botulinum toxin type-A are key factors propelling the global market
.By end-user, the therapeutics end-use segment dominates the global market, owing to global rise in the cases of migraine and increase in the demand for non-surgical therapeutic procedure, which is noninvasive or minimally invasive in nature
.By region, North America is the largest supplier of botox and dominates the global botox market, owing to the rise in awareness level regarding non-surgical esthetic and therapeutic procedures. The global market in North America is expected to maintain its dominant position over the forecast period. The global botox market in Europe is the second largest supplier of botox and is expected to expand over the forecast period, due to increase in geriatric population
Key Players:
.Allergan, Inc.
.Ipsen Pharma SA
.Merz Pharma GmbH & Co.
.KGaA
.Medytox, Inc.
.US Worldmed
.LLC
.Metabiologics, Inc.
.Lanzhou Institute of Biological Products Co. Ltd.
.Revance Therapeutics, Inc.
.Allergan, Inc.
.Ipsen Group
.Merz Pharma GmbH & Co.
Request sample PDF:
Questions by helium Market:
1.What are the key market trends and market dynamics?
2.Who are the major players in the market and what is their market share?
3.What is the competitive landscape like in the market?
4.What are the major drivers and restraints affecting the market?
5.What are the growth opportunities in the market?
6.What are the regional and local market conditions and consumer behavior?
7.What is the market size and growth forecast for different regions and countries?
8.What is the impact of government regulations and policies on the market?
Request a Customized link here:
About Prophecy Market Insights
Prophecy Market Insights is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.
Read Related Insights:
botox and dermal filler market -By Product (Biodegradable and Non-biodegradable), By Material (Botulinum Toxin, Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-lactic Acid, PMMA, and Fat), By Applications (Facial Line Correction Treatment, Lip Enhancement, and Scar Treatment), By End-User (Hospitals, Dermatology Clinics, and Ambulatory Surgical Centers), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2029
halal personal care products market -By Product (Personal Care Products and Color Cosmetics), By Distribution Channel (Online and Offline Retail Formats), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2029
Shweta Raskar
Prophecy Market Insights
+1 860-531-2701
email us here
Visit us on social media:
facebook
twitter
linkedin
youtube
MENAFN27032023003118003196ID1105876580
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.